跳至主要内容
临床试验/NCT03455231
NCT03455231已完成不适用

Short Course Accelerated Radiation Therapy (Sharon) in Complicated Bone Metastases Palliation

IRCCS Azienda Ospedaliero-Universitaria di Bologna0 个研究点目标入组 45 人开始时间: 2009年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
45
主要终点
Maximum tolerated dose

研究概览

简要总结

The study wants to define the maximum tolerated dose (MTD), safety and efficacy of a short course radiation treatment in patients with complicated bone metastases.

详细描述

The study wants to define the maximum tolerated dose (MTD) of a conformal short course radiation treatment delivered in twice daily fractions and 2 consecutive days, and the feasibility of this fractionation in term of safety and efficacy for symptomatic palliation of complicated bone metastases.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • radiologically proven complicated bone metastasis
  • age > 18 years
  • Eastern Cooperative Oncology Group (ECOG) performance status < 3

排除标准

  • prior RT to the same region

结局指标

主要结局

Maximum tolerated dose

时间窗: 1 year

The maximum tolerated dose is defined as the dose level below the highest administered dose associated with dose limiting toxicity (DLT) in at least one third of patients

次要结局

  • Quality of life(1 year)
  • Pain relief(1 year)
  • Acute toxicity(1 year)
  • Late toxicity(1 year)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Alessio Giuseppe Morganti

Professor

IRCCS Azienda Ospedaliero-Universitaria di Bologna

相似试验

Short Course Radiotherapy in Complicated Bone... | 临床试验